Navigation Links
ClearWay Minnesota(SM) Adds New Director of Research
Date:8/13/2009

MINNEAPOLIS, Aug. 13 /PRNewswire/ -- ClearWay Minnesota announced today that Dr. Raymond Boyle, Ph.D., M.P.H., will be the new Director of Research for the organization. Dr. Boyle has training in Health Education and Epidemiology from the University of Oregon and the University of Minnesota.

"We are very excited about this new addition to ClearWay Minnesota and our research department," said David Willoughby, Chief Executive Officer of ClearWay Minnesota. "Dr. Boyle is well respected in his work on tobacco control and will help us continue to achieve our goals of reducing the harm of tobacco in Minnesota."

Prior to joining ClearWay Minnesota, Dr. Boyle was with the Department of Family Medicine and Community Health at the University of Minnesota Medical School. He has served as a research investigator for 10 clinical trials involving a wide variety of research topics including smoking and snuff cessation, weight loss among health plan members and adolescent health. In addition, Dr. Boyle has published more than 50 papers in peer-reviewed scientific journals.

About ClearWay Minnesota(SM)

ClearWay Minnesota is an independent, non-profit organization that improves the health of Minnesotans by reducing the harm caused by tobacco. ClearWay Minnesota serves Minnesota through its grant-making program, QUITPLAN(R) stop-smoking services and statewide outreach activities. It is funded with 3 percent of the state's 1998 tobacco settlement. For more information on ClearWay Minnesota or QUITPLAN Services, call 952-767-1400 or visit clearwaymn.org.


'/>"/>
SOURCE ClearWay Minnesota
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. ClearWay Minnesota(SM) Board Approves Four Regional Grants
2. ClearWay Minnesota(SM) Board Approves New Officers
3. ClearWay Minnesota(SM) Board Approves $1.4 Million in New Grants to Reduce Tobaccos Harm
4. ClearWay Minnesota(SM) Celebrates 10-Year Anniversary of Settlement
5. ClearWay Minnesota(SM) Celebrates QUITPLAN(R) Services at the Capitol
6. ClearWay Minnesota(SM) Board Approves $2.8 Million for Research Grants
7. ClearWay Minnesota(SM) to Share Stories of Real Minnesotans Who Used QUITPLAN(R) Services During Great American Smokeout
8. Procter & Gamble Announces Appointment of Director
9. Webmedx Announces That CEO Sean Carroll Has Been Appointed to the AHIMA Foundation Board of Directors
10. Jeff Korte Named as SIU Director, Litigation Solutions, LLC
11. Jim Deal Appointed to MedCaths Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... ... 10, 2016 , ... Everseat has joined the award-winning Allscripts ... physicians. The integration will enable Allscripts users to post open appointments to the ... app. , The partnership gives Everseat substantial added power to help Allscripts meet ...
(Date:2/10/2016)... ... 10, 2016 , ... Workrite Ergonomics this week announced the launch of the ... , “Our goal was to develop a product from the ground up that ... ever created.” said Darren Hulsey, Product Manager for Workrite Ergonomics. “The Conform series ...
(Date:2/10/2016)... ... February 10, 2016 , ... Anxiety of older Americans over steep cost increases ... D a decade ago, according to The Senior Citizens League (TSCL). ... are coping with rapidly rising costs. “The implications are chilling, particularly for people ...
(Date:2/10/2016)... ... February 09, 2016 , ... ... Body Specialists are delighted to welcome a new addition to their growing practice. ... Body Specialists as a nurse practitioner performing cosmetic procedures including injectables, ...
(Date:2/10/2016)... (PRWEB) , ... February 10, 2016 , ... It’s that ... Traci Davis, the new president of the Interscholastic Athletic Association of Maryland (IAAM), Hall ... well how quickly fitness goals are cast aside. , That’s why one of her ...
Breaking Medicine News(10 mins):
(Date:2/9/2016)... February 9, 2016 ... heute den Abschluss eines Kooperationsvertrags mit 10x ... Lösungen in den Bereichen Next-Generation-Sequencing (NGS), Single-Cell-Biology ... ; Frankfurt Prime Standard: QIA) gab heute ... für die Entwicklung und Förderung umfassender Lösungen ...
(Date:2/9/2016)... Florida , February 9, 2016 ... today announced a collaboration with 10x Genomics to ... (NGS), single-cell biology and bioinformatics. --> ... a collaboration with 10x Genomics to develop and ... biology and bioinformatics. --> QIAGEN N.V. ...
(Date:2/9/2016)... , Feb. 9, 2016 Mast Therapeutics, ... clinical-stage therapies for sickle cell disease and heart failure, today ... and warrants to purchase common stock in an underwritten public ... and there can be no assurance as to whether or ... actual size or terms of the offering.   ...
Breaking Medicine Technology: